A3377612
Dexrazoxane , 97% , 24584-09-6
Synonym(s):
(+)-(S)-4,4′-Propylenedi-2,6-piperazinedione;(S)-(+)-1,2-Bis(3,5-dioxopiperazin-1-yl)propane;Cardioxane;Zinecard
Pack Size | Price | Stock | Quantity |
5MG | RMB31.20 | In Stock |
|
25MG | RMB55.20 | In Stock |
|
50MG | RMB63.20 | In Stock |
|
100MG | RMB127.20 | In Stock |
|
250mg | RMB176.80 | In Stock |
|
1g | RMB479.20 | In Stock |
|
5g | RMB1679.20 | In Stock |
|
25g | RMB5119.20 | In Stock |
|
others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
Melting point: | 194-196°C |
alpha | D +11.35° (c = 5 in DMF) |
Boiling point: | 531.5±50.0 °C(Predicted) |
Density | 1.333±0.06 g/cm3(Predicted) |
storage temp. | 2-8°C |
solubility | DMSO: >20mg/mL |
form | powder |
pka | 2.1(at 25℃) |
color | white to off-white |
Merck | 14,8123 |
InChIKey | BMKDZUISNHGIBY-ZETCQYMHSA-N |
CAS DataBase Reference | 24584-09-6(CAS DataBase Reference) |
Description and Uses
Dexrazoxane is the dextro-isomer of razoxane approved as a protectant against the cardiotoxicity of doxorubicin in breast cancer patients. This agent does not alter the anticancer effect of doxorubicin. Its mode of action suggests a chelation of free radicals. In mice, dexrazoxane also offers protection against cardiac side effects of epirubicin, but not mitoxantrone.
Cardioprotectant.
Safety
Symbol(GHS) | GHS07 |
Signal word | Warning |
Hazard statements | H315-H319-H335 |
Precautionary statements | P261-P264-P271-P280-P302+P352-P305+P351+P338 |
Hazard Codes | Xi |
Risk Statements | 36/37/38 |
Safety Statements | 26-36 |
RIDADR | UN 2811 6.1 / PGIII |
WGK Germany | 3 |
RTECS | TL6390000 |
HS Code | 2933.59.9500 |
Hazardous Substances Data | 24584-09-6(Hazardous Substances Data) |